Sec. 4. Overdose prevention research
224 words·~1 min read·
/bill/113/s/2755/is/section-4A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Subpart 15 of part C of title IV of the Public Health Service Act ( 42 U.S.C. 285o et seq. ) is amended by adding at the end the following: The Director of the Institute shall prioritize and conduct or support research on drug overdose and overdose prevention. The primary aims of this research shall include— an examination of circumstances that contribute to drug overdose and identification of drugs associated with fatal overdose; an evaluation of existing overdose prevention methods; pilot programs or research trials on new overdose prevention strategies or programs that have not been studied in the United States; scientific research concerning the effectiveness of overdose prevention programs, including how to effectively implement and sustain such programs; comparative effectiveness research of model programs; and implementation of science research concerning effective overdose prevention programming examining how to implement and sustain overdose prevention programming.
The Director of the Institute shall support research on the development of formulations of naloxone, and other similarly effective medications, and dosage delivery devices specifically intended to be used by lay persons or first responders for the prehospital treatment of unintentional drug overdose. In this section, the term drug has the meaning given such term in section 399OO. There are authorized to be appropriated to carry out this section $5,000,000 for each of the fiscal years 2015 through 2019. .
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 4
Overdose prevention research
Cites 1Cited by 0 across 0 sources